PET/MRI accurately predicts risk of prostate cancer recurrence after prostatectomy

In men recently diagnosed with intermediate or high-grade prostate cancer, prostate specific membrane antigen (PSMA), PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy. Armed with this information, physicians can identify patients who could benefit from additional treatment and/or frequent surveillance. This research was published in the December issue of the Journal of Nuclear Medicine.